Current Trends of Nanotechnology for Cancer Therapy
DOI:
https://doi.org/10.37285/ijpsn.2010.3.3.2Abstract
Nanoparticulate technology is of particular use in developing a new generation of more effective cancer therapies capable of overcoming many biological, biophysical and biomedical barriers that the body stages against a standard intervention. Targeted delivery of drug molecules to tumor tissue is one of the most interesting and challenging endeavors faced in pharmaceutical field, due to the critical and pharmacokinetically specific environment that exists in tumor. Over these years, cancer targeting treatment has been greatly improved by new tools and approaches based on nanotechnology. Nanoparticles show much promise in cancer therapy by selectively gaining access to tumor due to their small size and modifiability. In this review, nonmaterial and biomarkers of cancer, general principle of drug targeting to cancer, intracellular mechanisms, nanoparticles based formulation in market, several recent applications in medicine as diagnostic and therapeutic are discussed. The review’s basic approach is: the defining features of cancer nanotechnology are embedded in their breakthrough potential for design and development of nanoparticle based drugs.
Downloads
Metrics
Keywords:
Nanotechnology, Cancer, Nanomedicine, Biomarker
Downloads
Published
How to Cite
Issue
Section
References
A. A. Shvedova, E. R. Kisin, D. Porter. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: two faces of Janus? Pharmacology and Therapeutics 121: 192–204 (2009).
A. K. Iyer, G. Khaled, J. Fang, and H. Maeda. Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discovery Today 11: 812–818 (2006).
A. K. Patri, A. Myc, J. Beals, T. P. Thomas, N. H. Bander, and J. R. Baker Jr. Synthesis and in vitro testing of J591 antibodydendrimer conjugates for targeted prostate cancer therapy. Bioconjugate Chemistry 15: 1174–1181 (2004).
A. Surendiran, S. Sandhiya, S.C. Pradhan and C. Aditha. Novel applications of nanotechnology in medicine. Indian J Med Res 130: 689-701 (2009).
Aduro BT Berkeley: Oncologic and Triton BioSystems Merge to Form Aduro BioTech Aduro to Focus on NT™ and TNT™ Systems for Solid Tumor Cancers. (2008).
Alok Kumar Singha, Anjita Pandeyb, Rajani Raib, Mallika Tewarib, H.P. Pandeya, H.S. Shukla. Nanomaterials emerging tool in cancer diagnosis and treatment. Digest Journal of Nanomaterials and Biostructures 3: 135–140 (2008).
Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 49: 403-8 (2003).
Copland JA, Eghtedari M, Popov VL. Bioconjugated gold nanoparticles as a molecular based contrast agent: implications for imaging of deep tumors using optoacoustic Tomography. Mol Imaging Biol. 6: 341–349 (2004).
Cuenca AG, Jiang H, Hochwald SN, Delano M, Cance WG, Grobmyer SR. Emerging implications of nanotechnology on cancer diagnostics and therapeutics. Cancer 107: 459-66 (2006).
D. Bhadra, A. K. Yadav, S. Bhadra, and N. K. Jain. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. International Journal of Pharmaceutics 295: 221–233 (2005).
D. Li, G. P. Li, W. Guo, P. Li, E. Wang, and J. Wang. Glutathione-mediated release of functional plasmid DNA from positively charged quantum dots. Biomaterials 29: 2776–2782 (2008).
Dilipkumar Pal and Amit Kumar Nayak. Nanotechnology for Targeted Delivery in Cancer Therapeutics. Int. J of Pharma. Sc. Rev. and Res. 1: 1-5 (2010).
E. K. Yim, J. S. Park, Cervical cancer-specific markers, Expert Rev Proteomics 3: 21-36 (2006).
E. R. Gillies and J. M. J. Fr´echet. Dendrimers and dendritic polymers in drug delivery. Drug Discovery Today 10: 35–43 (2005).
F. H. Sarkar, S. Banerjee and Y. W. Li. Pancreatic cancer: pathogenesis, prevention and treatment. Toxicology and Applied Pharmacology 224: 326–336 (2007).
Folkman, J. and Shing, Y. Angiogenesis. J. Biol. Chem. 267: 10931 (1992).
Forssen EA, Coulter DM, Proffitt RT. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res 52: 3255-61 (2002).
G. Linazasoro. Potential applications of nanotechnologies to Parkinson’s disease therapy. Parkinsonism and Related Disorders 14: 383 –392 (2008).
Gref, R. Biodegradable long-circulating polymeric nanospheres. Science 263: 1600 (1994).
Gref, R. Poly (ethylene glycol) -coated nanospheres: Potential carriers for intravenous drug administration. Pharm. Biotechnol. 10: 167 (1997).
Gregoriadis G, Ryman BE. Fate of protein-containing liposomes injected into rats. An approach to the treatment of storage diseases. Eur J Biochem 24: 485-91 (1972).
Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B,Price RE, et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100: 13549-54 (2003).
Illum L and Davis SS. The organ uptake of intravenously administered colloidal particles can be altered using a nonionic surfactant (Poloxamer 338). FEBS Lett 167: 79-82 (1984).
J. D. Byrne, T. Betancourt and L. Brannon-Peppas. Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced Drug Delivery Reviews 60: 1615–1626 (2008).
Jain, R. K. Delivery of molecular and cellular medicine to solid tumors. J. Control. Release, 53: 49 (1998).
Jain, R. K. Integrative pathophysiology of solid tumors: Role in detection and treatment. Cancer J. Sci. Am. 4: S48 (1998).
K. J. Morrow Jr., R. Bawa, and C. Wei. Recent advances in basic and clinical nanomedicine. Medical Clinics of North America 91: 805–843 (2007).
K. K. Jain. Nanotechnology in clinical laboratory diagnostics. Clinica Chimica Acta 358: 37–54 (2005).
K. Y. Kim. Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine: Nanotechnology, Biology, and Medicine 3: 103–110 (2007).
Kirby C, Gregoriadis G. The effect of lipid composition of small unilamellar liposomes containing melphalan and vincristine on drug clearance after injection in mice. Biochem Pharmacol 32: 609-15 (2003).
Kircher, M. F., Mahmood, U., King, R. S., Weissleder, R. and Josephson, L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63: 8122–8125 (2003).
Knauth M, Egelhof T, Roth SU, Wirtz CR, Sartor K. Monocrystalline iron oxide nanoparticles : possible solution to the problem of surgically induced intracranial contrast enhancement in intraoperative MR imaging. AJNR Am J Neuroradiol 22: 99-102 (2001).
Kratschmer W, Lamb LD, Fostiropoulos K, Hoffman DR. Solid C60 : a new form of carbon. Nature 347: 354-8 (1990).
L. Lacerda, A. Bianco, M. Prato, and K. Kostarelos. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Advanced Drug Delivery Reviews 58: 1460–1470 (2006).
La Van, D. A., McGui re, T. and Langer R. Small -scale systems for in vivo drug delivery. Nature Biotechnol. 21: 1184–1191 (2003).
Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells for targeted photothermal ablation of tumor cells. Int J Nanomedicine 1: 149-54 (2006).
M. Hussain, M. Shchepinov, M. Sohail. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides. Journal of Controlled Release 99: 139–155 (2004).
M. Licciardi, G. Giammona, J. Du, S. P. Armes, Y. Tang, and A. L. Lewis. New folate-functionalized biocompatible block copolymer micelles as potential anti-cancer drug delivery systems. Polymer 47: 2946–2955 (2006).
Maeda, H. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control. Release 65: 271 (2000).
Maeda, H., Sawa, T., and Konno, T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release 74: 47 (2001).
McCormack B, Gregoriadis G. Drugs-in-cyclodextrins-inliposomes a novel concept in drug delivery. Int J Pharm 112: 249-58 (1994).
Minko, T. Molecular targeting of drug delivery systems to cancer. Curr. Drug Targets 5: 389 (2004).
Nam, J. M. and Mirkin, C. A. Bio -barcode-based DNA detection with PCR -like sensitivity. J. Am. Chem. Soc. 126: 5932–5933 (2004).
Neuwalt E. A. Imaging of iron oxide nanoparticles with MR and light microscopy in patients with malignant brain tumors. Neuropathol. Appl. Neurobiol. 5: 456–471 (2004).
Paciotti GF, Myer L, Weinreich D. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 11: 169–183 (2004).
Pan American Health Organisation, Regional Office of the World Health Organisation (WHO), Cancer (WHO Fact Sheet No. 297), (2006).
Panyam, J. and Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55: 329 (2003).
Park J. W. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res. 4: 95–99 (2002).
Peng XH, Qian X, Mao H, Wang AY, Chen Z, Nie S. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine 3: 311-21 (2008).
Piotr Grodzinski. Nanotechnology in cancer, NCI Alliance for Nanotechnology in cancer, Bethesda, MD 20892 (2010).
Qiu LY, Bae YH. Polymer architecture and drug delivery. Pharm Res. 23: 1-30 (2006).
R. Sharma and C. J. Chen. Newer nanoparticles in hyperthermia treatment and thermometry. Journal of Nanoparticle Research 11: 671–689 (2009).
S. Klein, O. Zolk, M. F. Fromm, F. Schr¨odl, W. Neuhuber, and C. Kryschi. Functionalized silicon quantum dots tailored for targeted siRNA delivery. Biochemical and Biophysical Research Communications 387: 164–168 (2009).
Sahoo, S. K., Ma, W., and Labhasetwar, V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int. J. Cancer. 112: 335 (2004).
Senior J, Delgado C, Fisher D, Tilcock C, Gregoriadis G. Influence of surface hydrophilicity of liposomes on their interaction with plasma-protein and clearance from the circulation – studies with poly (ethylene glycol)-coated vesicles. Biochim Biophys Acta 1062: 77-82 (1999).
Shuming Nie, Yun Xing, Gloria J. Kim and Jonathan W. Simons. Nanotechnology Applications in Cancer. Annu. Rev. Biomed. Eng. 9: 12.1 –12.32 (2007).
Shuming Nie, Yun Xing, Gloria J. Kim, and JonathanW. Simons. Nanotechnology Applications in Cancer. Annu. Rev. Biomed. Eng. 9: 257-288 (2007).
Sokolov K, Follen M, Aaron J. Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 63: 1999–2004 (2003).
T. Tanaka, S. Shiramoto, M. Miyashita, Y. Fujishima, and Y. Kaneo. Tumor targeting based on the effect of enhanced permeability and retention (EPR) and the mechanism of receptor-mediated endocytosis (RME). International Journal of Pharmaceutics 277: 39–61 (2004).
Taylor R, Hare JP, Abdul-Sada AK, Kroto HW. Isolation, separation and characterisation of the fullerenes C60 and C70: the third form of carbon. J Chem Soc Chem Commun 20: 1423-5 (1990).
Thakral S, Mehta RM. Fullerenes : an introduction and overview of their biological properties. Indian J Pharm Sci 68: 13-9 (2006).
Torchilin VP, Shtilman MI, Trubetskoy VS, Whiteman K, Milstein AM. Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. Biochim Biophys Acta 1195: 181-4 (1994).
Vasir, J. K. and Labhasetwar, V. Targeted drug delivery in cancer therapy. Technol. Cancer Res. Treat. 4: 363 (2005).
W. C. Cho. Research progress in SELDI-TOF MS and its clinical applications. Sheng Wu Gong Cheng Xue Bao 22: 871-876 (2006).
W. C. S. Cho, Nanotechnology in cancer, Molecular Cancer 6: 25 (2007).
W. Cai and X. Chen. Nanoplatforms for targeted molecular imaging in living subjects. Small 3: 1840–1854 (2007).
W. J. Yang, Y. Y. Cheng, T. W. Xu, X. Y. Wang, and L. P. Wen. Targeting cancer cells with biotine-dendrimer conjugates. European Journal of Medicinal Chemistry 44: 862–868 (2009).
West JL, Halas NJ. Applications of nanotechnology to biotechnology commentary. Curr Opin Biotechnol 11: 215-7 (2000).
Whitesides, G. M. The ‘right’ size in nanotechnology. Nature Biotechnol. 21: 1161–1165 (2003).
Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev. 59: 491-504 (2007).
Y. Choi, T. Thomas, A. Kotlyar, M. T. Islam, and J. R. Baker Jr. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting. Chemistry and Biology 12: 35–43 (2005).
Young-Eun Choi, Ju-Won Kwak and Joon Won Park. Nanotechnology for Early Cancer Detection. Sensors 10: 428-455 (2010).
Zheng G, Patolsky F, Lieber CM. Nanowire biosensors: a tool for medicine and life science. Nanomed: Nanotech Biol Med 2: 277 (2006).
